Life Science Forum 2019

Thank you for joining the Life Science Forum 2019.

On 14 November 2019, the Life Science Forum was hosted at Deutsche Bank, in partnership with AstraZeneca and the Embassy of Sweden in London, bringing together some 100 guests. Discussing "Medicine for me and the millions, how do we get there?", the forum featured Leif Johansson, Chairman of AstraZeneca bringing the big pharma perspective - and a true Swedish-British partnership; Dr Johan Christenson of Swedish VC fund HealthCap talking about the venture model in biotech and life science; Ross Hammerman at Deutsche Bank showing where the investment dollars are going, and Kristina Lagerstedt, CEO and founder of 1928 Diagnostics, talking about her start-up journey, and the impact they're having on the world stage. 

See photos from the Life Science Forum 2019 here

Agenda

18.30
Registration, welcome drinks & networking

19.00
Welcome
Jan Olsson, Chairman of the Swedish Chamber of Commerce and CEO Nordics at Deutsche Bank

Introduction
H.E. Torbjörn Sohlström the Ambassador of Sweden to the UK

The capital markets and where the investment dollars are going
Ross Hammerman, Co-Head of Americas Healthcare Investment Banking, Deutsche Bank AG
A deep dive into the current key M&A and capital markets trends in the life science sector.

Innovation in pharmaceuticals – how to go from buzz to patient
Leif Johansson, Non-Executive Chairman of the Board, AstraZeneca
How do we create symbiotic collaborations within the pharmaceutical industry and increase innovation and productivity?

Biotech mind blowing ideas and cool concepts – what do we really need for the future?
Dr. Johan Christenson, Partner, HealthCap
The way from innovation to patient, and a look at how the venture model has changed. Dr. Johan Christenson explores the next-generation ideas within biotech and their applications for patient benefit.

Diagnosing disease, why bother?
Kristina Lagerstedt, CEO 1928 Diagnostics
How can healthtech improve disease diagnosis? Dr. Kristina Lagerstedt also looks at how building a healthtech business requires strong networks and collaborations.

Panel Q&A
Panel with all speakers, moderated by Ross Hammerman

20:30
Drinks & networking

Booking information

SCC member Price: £45
YP member Price: £45
Non-member Price: £135
Academics and small biotech: £45 (please contact events@scc.org.uk for this special rate)

About Life Science Forum

The Swedish Chamber of Commerce’s range of Forums are aimed at bringing specific sector stakeholders together, and highlighting ties and opportunities between Sweden and Britain. Whilst targeting the life sciences community – pharma, biotech, venture, investment, academics – we welcome the broader Swedish-British business community to participate.

Life Science Forum 2019

On 14 November, the Swedish Chamber of Commerce arranged Life Science Forum 2019 at the premises of Deutsche Bank in central London. The event was generously sponsored by AstraZeneca, Deutsche Bank and the Embassy of Sweden in London.

Speakers 2019

Dr. Johan Christenson

Dr. Johan Christenson

Partner, HealthCap

Dr. Johan Christenson has been a Partner at HealthCap since 2001. He has been in the life science sector covering science, medicine, drug development and venture investments since 1981. Prior to joining HealthCap, Dr. Christenson was with SEB Företagsinvest (the venture capital arm of SEB) to supervise the health care portfolio. He was Global Product Director and member of the global therapy area management team of Pain and Inflammation at AstraZeneca. He has an MD degree and a PhD in basic neuroscience from Karolinska Institute. He held a position as Assistant Dean at the Karolinska Institute Graduate School for two years.

Ross Hammerman

Ross Hammerman

Co-Head of Americas Healthcare Investment Banking, Global Head of Life Sciences, Deutsche Bank AG

Ross Hammerman has 19+ years of investment banking experience and joined Deutsche Bank in October 2016. Prior to joining Deutsche Bank, he worked at UBS as Global Head of Life Sciences. Ross has previously worked at Citigroup in Healthcare Investment Banking and Lehman Brothers. He is medically trained in Ob/Gynat the Albert Einstein College of Medicine.

Leif Johansson

Leif Johansson

Non-Executive Chairman of the Board, AstraZeneca

From 1997 to 2011, Leif Johansson was Chief Executive Officer of Volvo. Prior to that, he served at Electrolux, latterly as Chief Executive Officer from 1994 to 1997. He was a Non-Executive Director of BMS from 1998 to September 2011, serving on the Board’s Audit Committee, and Compensation and Management Development Committee. Leif was Chairman of global telecommunications company, LM Ericsson, from 2011 until March 2018. He holds an MSc in engineering from Chalmers University of Technology, Gothenburg. Leif holds board positions at Autoliv, Inc and Ecolean. He has been a member of the Royal Swedish Academy of Engineering Sciences since 1994 (Chairman 2012 to 2017). Leif is also a member of the European Round Table of Industrialists (Chairman 2009 to 2014) and a Member of the Council of Advisors, Boao Forum for Asia.

Dr. Kristina Lagerstedt

Dr. Kristina Lagerstedt

CEO, 1928 Diagnostics

Dr Kristina Lagerstedt is a health-tech entrepreneur, cancer scientists and expert in DNA-science and a member of Digital Leaders Europe. Kristina is a founder and the CEO of 1928 Diagnostics (Technology Pioneer Champion by World Economic Forum in 2018) providing a software service that decodes DNA from bacteria to guide hospitals to identify and stop deadly outbreaks of antibiotic resistant bacteria. Dr. Lagerstedt was previously a clinical cancer scientist at Sahlgrenska University hospital, Gothenburg, Sweden focused on identifying and commercializing molecular biomarkers and detect new treatment targets to guide and improve cancer treatment.

Jan Olsson.

Jan Olsson.

Chairman, Swedish Chamber of Commerce

Jan joined Deutsche Bank in 1988 and has held several positions within M&A, Structured Finance and Corporate Finance. He holds a BA from Pomona College, an MBA from Wharton, an MA from University of Pennsylvania, and a Graduate Diploma in Business Studies from the London School of Economics.

H.E. Mr Torbjörn Sohlström.

H.E. Mr Torbjörn Sohlström.

Ambassador of Sweden to the United Kingdom, Embassy of Sweden

H.E. Torbjörn Sohlström is the Swedish Ambassador to the UK. The Ambassador initially worked in journalism before joining the Swedish Foreign Service. He has worked for the EU at the EU Council Secretariat in Brussels and has had senior postings in Skopje and Pristina, including working as Personal Representative of Javier Solana. He then returned from the EU to the Swedish Foreign Service as Deputy Head of the Mission in Russia, and has held senior positions in Sweden as Deputy Director General and Head of the Minister’s Office, followed by Director General for Political Affairs.

Keep in touch on social

What if Juliet would not have ended her life after her tragic fate with Romeo? Last night we got a glimpse of Juliet’s alternative future, set to the well-known tunes of Swedish songwriter and producer Max Martin, at the new West End musical & Juliet. https://t.co/GrnlvWeOd0
We are happy to welcome Richard Hildebrand, Founder of TandonHildebrand @TandonHild, and Patrik Högberg, Managing Director of @LoomisUK, as two of the mentors of the SCC Mentorship Programme 2020. Read more and apply here: https://t.co/0DXLWcZpap #SCCMentorshipProgramme #yp #UK
The SCC is proud to announce Handelsbanken Wealth Management as the official sponsor of the Christmas Luncheon 2019. Handelsbanken Wealth Management aims to help customers to secure their financial future, by offering a joined-up approach to the customers’ finances. #SCC #UK

Join our mailing list